Oncology
Revealing the molecular mechanism of tumor development and identifying the matching inhibitory candidates is one important area within the cancer research.
The tumor diversity is extremely high. Therefore, cancer research belongs to the high variant research areas with manifold scientific approaches.
To match this challenge, we offer you a unique diversity of products for your oncology research and development in the academic and pharmaceutical field.
Click on the organs and learn more about cancer types
General information
Oncologists focus on the diagnosis, therapy and follow-up of cancer.
Cancer is a class of diseases in which cells start to divide uncontrollably and invade other tissues. Cancer cells can spread to other parts of the body via the blood and lymphatic system. Under physiological conditions, cell proliferation is tightly controlled by many mechanisms. In addition, the immune system is able to recognize and destroy cancer cells. If these mechanisms fail or the immune system cannot effectively destroy the cells, it can lead to a malignant tumor. Theoretically, a malignant neoplasm can occur everywhere, but there are cancers that are more often than others. For men it is the prostate and in women it is the mammary gland.
Relevant products for oncology research
| Name | Price | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Research Grade Gancotamab | Login | Research Grade Gancotamab | ||||||||||||||||
|
||||||||||||||||||
| Research Grade Zanidatamab | Login | Research Grade Zanidatamab | ||||||||||||||||
|
||||||||||||||||||
| Research Grade Ertumaxomab | Login | Research Grade Ertumaxomab | ||||||||||||||||
|
||||||||||||||||||
| Research Grade Zenocutuzumab | Login | Research Grade Zenocutuzumab | ||||||||||||||||
|
||||||||||||||||||
| Research Grade Modotuximab | Login | Research Grade Modotuximab | ||||||||||||||||
|
||||||||||||||||||
| Research Grade Tomuzotuximab | Login | Research Grade Tomuzotuximab | ||||||||||||||||
|
||||||||||||||||||
| Research Grade Depatuxizumab | Login | Research Grade Depatuxizumab | ||||||||||||||||
|
||||||||||||||||||
| Research Grade Demupitamab | Login | Research Grade Demupitamab | ||||||||||||||||
|
||||||||||||||||||
| Research Grade Zatuximab | Login | Research Grade Zatuximab | ||||||||||||||||
|
||||||||||||||||||
| Research Grade Imgatuzumab | Login | Research Grade Imgatuzumab | ||||||||||||||||
|
||||||||||||||||||
| Research Grade Laprituximab | Login | Research Grade Laprituximab | ||||||||||||||||
|
||||||||||||||||||
| Research Grade Losatuxizumab | Login | Research Grade Losatuxizumab | ||||||||||||||||
|
||||||||||||||||||
| Research Grade Nimotuzumab | Login | Research Grade Nimotuzumab | ||||||||||||||||
|
||||||||||||||||||
| Research Grade Serclutamab | Login | Research Grade Serclutamab | ||||||||||||||||
|
||||||||||||||||||
| Research Grade Zalutumumab | Login | Research Grade Zalutumumab | ||||||||||||||||
|
||||||||||||||||||
| Research Grade Pimurutamab | Login | Research Grade Pimurutamab | ||||||||||||||||
|
||||||||||||||||||
| Research Grade Petosemtamab | Login | Research Grade Petosemtamab | ||||||||||||||||
|
||||||||||||||||||
| Research Grade Crenezumab | Login | Research Grade Crenezumab | ||||||||||||||||
|
||||||||||||||||||
| Research Grade Donanemab | Login | Research Grade Donanemab | ||||||||||||||||
|
||||||||||||||||||
| Research Grade Gantenerumab | Login | Research Grade Gantenerumab | ||||||||||||||||
|
||||||||||||||||||
| Research Grade Aducanumab | Login | Research Grade Aducanumab | ||||||||||||||||
|
||||||||||||||||||
| Research Grade Solanezumab | Login | Research Grade Solanezumab | ||||||||||||||||
|
||||||||||||||||||
| Research Grade Bapineuzumab | Login | Research Grade Bapineuzumab | ||||||||||||||||
|
||||||||||||||||||
| Research Grade Taplitumomab | Login | Research Grade Taplitumomab | ||||||||||||||||
|
||||||||||||||||||
| Research Grade Girentuximab | Login | Research Grade Girentuximab | ||||||||||||||||
|
||||||||||||||||||


